NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS
申请人:JANUS BIOTHERAPEUTICS, INC.
公开号:US20140242121A1
公开(公告)日:2014-08-28
The present invention relates to a compound of Formula I: or an enantiomer, diastereomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same.